(FLYW) Flywire - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 1.387m USD | Total Return: 21.1% in 12m
Avg Trading Vol: 19.4M USD
Peers RS (IBD): 73.5
EPS Trend: 44.0%
Qual. Beats: 0
Rev. Trend: 89.1%
Qual. Beats: 6
P/E ratio: 103.2727
Technicals: choppyFlywire Corp (NASDAQ: FLYW) is a Boston-based payments enablement and software firm that operates globally across education, healthcare, travel, and B2B segments. Its platform supports multi-currency, multi-method transactions and offers direct integrations with alternatives such as Alipay, Boleto, PayPal/Venmo, and Trustly, allowing clients to receive payments and customers to pay more seamlessly.
In its most recent fiscal year (2023), Flywire generated $1.07 billion in revenue, up 27% year-over-year, driven by strong growth in the education and healthcare verticals. The company reported a cash balance of roughly $300 million and a net loss of $30 million, reflecting continued investment in product expansion and international scaling. Macro-level, global cross-border payment volumes are projected to grow at a 5% CAGR through 2027, providing a favorable tailwind for Flywire’s multi-currency network.
For deeper insights, you might explore ValueRay’s analysis of Flywire.
- Global expansion of payment platform drives revenue growth
- Healthcare and education sector adoption boosts transaction volumes
- Regulatory changes in international payments increase compliance costs
- Competition from established payment processors impacts market share
- Macroeconomic slowdowns reduce cross-border transaction activity
| Net Income: 13.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.34 > 1.0 |
| NWC/Revenue: 32.19% < 20% (prev 96.13%; Δ -63.95% < -1%) |
| CFO/TA 0.08 > 3% & CFO 100.2m > Net Income 13.5m |
| Net Debt (-330.3m) to EBITDA (238.7m): -1.38 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.7m) vs 12m ago 2.64% < -2% |
| Gross Margin: 56.54% > 18% (prev 0.58%; Δ 5.60k% > 0.5%) |
| Asset Turnover: 52.45% > 50% (prev 43.85%; Δ 8.60% > 0%) |
| Interest Coverage Ratio: 1.11 > 6 (EBITDA TTM 238.7m / Interest Expense TTM 187.7m) |
| A: 0.16 (Total Current Assets 602.3m - Total Current Liabilities 401.8m) / Total Assets 1.25b |
| B: -0.13 (Retained Earnings -157.4m / Total Assets 1.25b) |
| C: 0.18 (EBIT TTM 209.2m / Avg Total Assets 1.19b) |
| D: -0.37 (Book Value of Equity -154.9m / Total Liabilities 418.1m) |
| Altman-Z'' Score: 1.43 = BB |
| DSRI: 1.29 (Receivables 210.8m/129.3m, Revenue 623.0m/492.1m) |
| GMI: 1.02 (GM 56.54% / 57.94%) |
| AQI: 1.64 (AQ_t 0.50 / AQ_t-1 0.31) |
| SGI: 1.27 (Revenue 623.0m / 492.1m) |
| TATA: -0.07 (NI 13.5m - CFO 100.2m) / TA 1.25b) |
| Beneish M-Score: -2.26 (Cap -4..+1) = BBB |
Over the past week, the price has changed by -6.61%, over one month by -6.84%, over three months by -16.69% and over the past year by +21.13%.
- StrongBuy: 4
- Buy: 2
- Hold: 9
- Sell: 1
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 16.3 | 40.1% |
| Analysts Target Price | 16.3 | 40.1% |
P/E Forward = 20.5339
P/S = 2.2268
P/B = 1.7299
Revenue TTM = 623.0m USD
EBIT TTM = 209.2m USD
EBITDA TTM = 238.7m USD
Long Term Debt = 15.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 15.0m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -330.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.05b USD (1.39b + Debt 15.0m - CCE 355.0m)
Interest Coverage Ratio = 1.11 (Ebit TTM 209.2m / Interest Expense TTM 187.7m)
EV/FCF = 10.97x (Enterprise Value 1.05b / FCF TTM 95.4m)
FCF Yield = 9.11% (FCF TTM 95.4m / Enterprise Value 1.05b)
FCF Margin = 15.32% (FCF TTM 95.4m / Revenue TTM 623.0m)
Net Margin = 2.17% (Net Income TTM 13.5m / Revenue TTM 623.0m)
Gross Margin = 56.54% ((Revenue TTM 623.0m - Cost of Revenue TTM 270.8m) / Revenue TTM)
Gross Margin QoQ = 59.64% (prev 63.87%)
Tobins Q-Ratio = 0.84 (Enterprise Value 1.05b / Total Assets 1.25b)
Interest Expense / Debt = 1.23k% (Interest Expense 184.7m / Debt 15.0m)
Taxrate = 37.05% (7.94m / 21.4m)
NOPAT = 131.7m (EBIT 209.2m * (1 - 37.05%))
Current Ratio = 1.50 (Total Current Assets 602.3m / Total Current Liabilities 401.8m)
Debt / Equity = 0.02 (Debt 15.0m / totalStockholderEquity, last quarter 835.2m)
Debt / EBITDA = -1.38 (Net Debt -330.3m / EBITDA 238.7m)
Debt / FCF = -3.46 (Net Debt -330.3m / FCF TTM 95.4m)
Total Stockholder Equity = 810.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.14% (Net Income 13.5m / Total Assets 1.25b)
RoE = 1.67% (Net Income TTM 13.5m / Total Stockholder Equity 810.2m)
RoCE = 25.34% (EBIT 209.2m / Capital Employed (Equity 810.2m + L.T.Debt 15.0m))
RoIC = 15.60% (NOPAT 131.7m / Invested Capital 844.0m)
WACC = 8.72% (E(1.39b)/V(1.40b) * Re(8.81%) + (debt cost/tax rate unavailable))
Discount Rate = 8.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.44%
[DCF] Terminal Value 67.47% ; FCFF base≈93.0m ; Y1≈61.1m ; Y5≈27.9m
[DCF] Fair Price = 6.88 (EV 491.0m - Net Debt -330.3m = Equity 821.3m / Shares 119.3m; r=8.72% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 43.98 | EPS CAGR: 137.0% | SUE: -0.25 | # QB: 0
Revenue Correlation: 89.12 | Revenue CAGR: 26.86% | SUE: 3.42 | # QB: 6
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=+0.001 | Chg30d=+0.002 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-12-31): EPS=0.95 | Chg7d=-0.003 | Chg30d=+0.077 | Revisions Net=+7 | Growth EPS=+103.2% | Growth Revenue=+20.1%
EPS next Year (2027-12-31): EPS=1.21 | Chg7d=-0.003 | Chg30d=+0.064 | Revisions Net=+4 | Growth EPS=+27.1% | Growth Revenue=+15.1%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.8% (Discount Rate 8.8% - Earnings Yield 1.0%)
[Growth] Growth Spread = +11.3% (Analyst 19.1% - Implied 7.8%)